{"transactions":[{"id":717828,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T21:58:29.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":17731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2027 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":17731,"derivative":{"exercise_price":38.96,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":17731},"source":{"system":"sec-edgar","filing":"0001334505-26-000002","document":"form4-07022026_090725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000133450526000002/form4-07022026_090725.xml","form_type":"4"}},{"id":1095063,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:45:39.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2026 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.73,"expiration_date":"2035-06-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-019091","document":"form4-07022025_080736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000141588925019091/form4-07022025_080736.xml","form_type":"4"}},{"id":1104763,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:15:19.000Z","date":"2025-06-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":0.95,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-25-017825","document":"form4-06202025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000141588925017825/form4-06202025_040607.xml","form_type":"4"}},{"id":1104762,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:15:19.000Z","date":"2025-06-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.48,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-25-017825","document":"form4-06202025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000141588925017825/form4-06202025_040607.xml","form_type":"4"}},{"id":1104761,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:15:19.000Z","date":"2025-06-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":3.53,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001415889-25-017825","document":"form4-06202025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000141588925017825/form4-06202025_040607.xml","form_type":"4"}},{"id":1104760,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:15:19.000Z","date":"2025-06-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":24.18,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":5150},"source":{"system":"sec-edgar","filing":"0001415889-25-017825","document":"form4-06202025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000141588925017825/form4-06202025_040607.xml","form_type":"4"}},{"id":1104759,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T20:15:19.000Z","date":"2025-06-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":28.58,"expiration_date":"2031-03-24","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0001415889-25-017825","document":"form4-06202025_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000141588925017825/form4-06202025_040607.xml","form_type":"4"}},{"id":1104758,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:15:19.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":false,"shares":11333,"price":0.57,"value":6459.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 1, 2025, by and among Kronos Bio, Inc. (the \"Issuer\"), Concentra Biosciences, LLC (\"Parent\") and Concentra Merger Sub IV, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On June 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $0.57 per Share in cash (the \"Cash Amount\"), and (ii) one non-transferable contractual contingent value right (each, a \"CVR\"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\").[continues to Footnote 2]"},{"field":"shares","element":"transactionShares","label":"F2","text":"[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-017825","document":"form4-06202025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000141588925017825/form4-06202025_040607.xml","form_type":"4"}},{"id":1465733,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T22:26:12.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 28, 2025 or\none (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":2.35,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-018665","document":"form4-07012024_100709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000141588924018665/form4-07012024_100709.xml","form_type":"4"}},{"id":1468652,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-26T20:34:43.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":34000,"derivative":{"exercise_price":0.95,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-24-018235","document":"form4-06262024_080639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000141588924018235/form4-06262024_080639.xml","form_type":"4"}},{"id":1839605,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T20:30:24.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2024 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":40000,"derivative":{"exercise_price":6.9,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-040593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919123040593/doc4.xml","form_type":"4"}},{"id":1844073,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T20:13:09.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":34000,"derivative":{"exercise_price":1.48,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-23-039692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000120919123039692/doc4.xml","form_type":"4"}},{"id":2214599,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-05T21:32:42.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2023 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":7.64,"expiration_date":"2032-06-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-040860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919122040860/doc4.xml","form_type":"4"}},{"id":2219254,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T20:15:21.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":17000,"derivative":{"exercise_price":3.53,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-22-039790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000120919122039790/doc4.xml","form_type":"4"}},{"id":2219253,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-29T20:15:21.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11333,"source":{"system":"sec-edgar","filing":"0001209191-22-039790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000120919122039790/doc4.xml","form_type":"4"}},{"id":2644506,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T21:02:42.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":7368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2022 or one (1) day prior to Issuer's next annual meeting occurring after the grant date, in each case, provided the Reporting Person continues to serve as a member of the Issuer's board of directors through the applicable vesting date."}],"balance_after":7368,"derivative":{"exercise_price":93,"expiration_date":"2031-06-29","underlying":"Common Stock","underlying_shares":7368},"source":{"system":"sec-edgar","filing":"0001209191-21-045064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919121045064/doc4.xml","form_type":"4"}},{"id":2656897,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-24T01:22:45.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":5150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":5150,"derivative":{"exercise_price":24.18,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":5150},"source":{"system":"sec-edgar","filing":"0001209191-21-042892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000120919121042892/doc4.xml","form_type":"4"}},{"id":2770361,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-03-26T17:41:39.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in three equal annual installments following the date of grant."}],"balance_after":41200,"derivative":{"exercise_price":28.58,"expiration_date":"2031-03-24","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0001209191-21-023181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334505/000120919121023181/doc4.xml","form_type":"4"}},{"id":3091743,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-03T01:14:22.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":5417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest upon the earlier of June 30, 2021 or one (1) day prior to the Issuer's next annual meeting occurring after the grant date, provided the Reporting Person continues to serve as a member of the Issuer's Board through the applicable vesting date."}],"balance_after":5417,"derivative":{"exercise_price":54.12,"expiration_date":"2030-06-29","underlying":"Common Stock","underlying_shares":5417},"source":{"system":"sec-edgar","filing":"0001209191-20-040831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919120040831/doc4.xml","form_type":"4"}},{"id":3335171,"issuer":{"id":4388,"kind":"organization","name":"Kodiak Sciences Inc."},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"Yang Taiyin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-19T22:43:23.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":8855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares subject to the option vests on first anniversary of the grant date and 1/36th of the shares subject to the option vest on each month thereafter on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month), in each case, provided that the Reporting Person continues to serve as a member of the Board through the applicable vesting date."}],"balance_after":8855,"derivative":{"exercise_price":71.2,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001209191-19-061390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1468748/000120919119061390/doc4.xml","form_type":"4"}},{"id":581595,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-05-03T00:08:58.000Z","date":"2007-05-02","kind":"sale","acquired":false,"shares":1300,"price":83.79,"value":108927.0,"ownership":{"direct":true},"balance_after":146381,"source":{"system":"sec-edgar","filing":"0001179110-07-008969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008969/edgar.xml","form_type":"4"}},{"id":581594,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-05-03T00:08:58.000Z","date":"2007-05-02","kind":"sale","acquired":false,"shares":1600,"price":83.74,"value":133984.0,"ownership":{"direct":true},"balance_after":147681,"source":{"system":"sec-edgar","filing":"0001179110-07-008969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008969/edgar.xml","form_type":"4"}},{"id":581593,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-05-03T00:08:58.000Z","date":"2007-05-02","kind":"sale","acquired":false,"shares":1700,"price":83.77,"value":142409.0,"ownership":{"direct":true},"balance_after":149281,"source":{"system":"sec-edgar","filing":"0001179110-07-008969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008969/edgar.xml","form_type":"4"}},{"id":581592,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-05-03T00:08:58.000Z","date":"2007-05-02","kind":"sale","acquired":false,"shares":14500,"price":83.75,"value":1214375.0,"ownership":{"direct":true},"balance_after":150981,"source":{"system":"sec-edgar","filing":"0001179110-07-008969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008969/edgar.xml","form_type":"4"}},{"id":581591,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-05-03T00:08:58.000Z","date":"2007-05-02","kind":"sale","acquired":false,"shares":500,"price":83.78,"value":41890.0,"ownership":{"direct":true},"balance_after":165481,"source":{"system":"sec-edgar","filing":"0001179110-07-008969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008969/edgar.xml","form_type":"4"}},{"id":581590,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-05-03T00:08:58.000Z","date":"2007-05-02","kind":"sale","acquired":false,"shares":400,"price":83.76,"value":33504.0,"ownership":{"direct":true},"balance_after":165981,"source":{"system":"sec-edgar","filing":"0001179110-07-008969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007008969/edgar.xml","form_type":"4"}},{"id":585467,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-23T00:25:30.000Z","date":"2007-02-21","kind":"sale","acquired":false,"shares":2200,"price":73.79,"value":162338.0,"ownership":{"direct":true},"balance_after":166381,"source":{"system":"sec-edgar","filing":"0001179110-07-004569","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007004569/edgar.xml","form_type":"4"}},{"id":585466,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-23T00:25:30.000Z","date":"2007-02-21","kind":"sale","acquired":false,"shares":200,"price":73.73,"value":14746.0,"ownership":{"direct":true},"balance_after":168581,"source":{"system":"sec-edgar","filing":"0001179110-07-004569","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007004569/edgar.xml","form_type":"4"}},{"id":585465,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-23T00:25:30.000Z","date":"2007-02-21","kind":"sale","acquired":false,"shares":2300,"price":73.7,"value":169510.0,"ownership":{"direct":true},"balance_after":168781,"source":{"system":"sec-edgar","filing":"0001179110-07-004569","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007004569/edgar.xml","form_type":"4"}},{"id":585464,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-23T00:25:30.000Z","date":"2007-02-21","kind":"sale","acquired":false,"shares":400,"price":73.78,"value":29512.0,"ownership":{"direct":true},"balance_after":171081,"source":{"system":"sec-edgar","filing":"0001179110-07-004569","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007004569/edgar.xml","form_type":"4"}},{"id":585463,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-23T00:25:30.000Z","date":"2007-02-21","kind":"sale","acquired":false,"shares":300,"price":73.74,"value":22122.0,"ownership":{"direct":true},"balance_after":171481,"source":{"system":"sec-edgar","filing":"0001179110-07-004569","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007004569/edgar.xml","form_type":"4"}},{"id":585462,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-23T00:25:30.000Z","date":"2007-02-21","kind":"sale","acquired":false,"shares":14600,"price":73.71,"value":1076166.0,"ownership":{"direct":true},"balance_after":171781,"source":{"system":"sec-edgar","filing":"0001179110-07-004569","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007004569/edgar.xml","form_type":"4"}},{"id":586713,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-08T00:12:13.000Z","date":"2007-02-06","kind":"sale","acquired":false,"shares":15900,"price":70.22,"value":1116498.0,"ownership":{"direct":true},"balance_after":186381,"source":{"system":"sec-edgar","filing":"0001179110-07-003135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007003135/edgar.xml","form_type":"4"}},{"id":586712,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2007-02-08T00:12:13.000Z","date":"2007-02-06","kind":"sale","acquired":false,"shares":4100,"price":70.24,"value":287984.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of Securities Beneficially Owned  Following Reported Transaction (s) (Table 1, Col. 5) includes 720 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 30, 2006."}],"balance_after":202281,"source":{"system":"sec-edgar","filing":"0001179110-07-003135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007003135/edgar.xml","form_type":"4"}},{"id":588380,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2007-01-24T21:46:32.000Z","date":"2007-01-22","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a five year period beginning 1/22/2008, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, ending on 1/22/2012."}],"balance_after":40000,"derivative":{"exercise_price":65.58,"expiration_date":"2017-01-22","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001179110-07-001858","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911007001858/edgar.xml","form_type":"4"}},{"id":602729,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Non-qualified Stock Option (right to buy)","published_at":"2006-07-28T20:53:45.000Z","date":"2006-07-26","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a five year vesting schedule. 20% of the options will vest on July 26, 2007, the first anniversary date of the grant.  The balance will vest 5% every three months thereafter until fully vested on July 26, 2011."}],"balance_after":30000,"derivative":{"exercise_price":61.89,"expiration_date":"2016-07-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001179110-06-015730","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006015730/edgar.xml","form_type":"4"}},{"id":616750,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":9891,"price":61.1,"value":604340.1,"ownership":{"direct":true},"balance_after":205661,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616749,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":1800,"price":61.11,"value":109998.0,"ownership":{"direct":true},"balance_after":215552,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616748,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":1500,"price":61.13,"value":91695.0,"ownership":{"direct":true},"balance_after":217352,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616747,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":3999,"price":61.14,"value":244498.86,"ownership":{"direct":true},"balance_after":218852,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616746,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":100,"price":61.19,"value":6119.0,"ownership":{"direct":true},"balance_after":222851,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616745,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":200,"price":61.18,"value":12236.0,"ownership":{"direct":true},"balance_after":222951,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616744,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":200,"price":61.2,"value":12240.0,"ownership":{"direct":true},"balance_after":223151,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616743,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":500,"price":61.21,"value":30605.0,"ownership":{"direct":true},"balance_after":223351,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616742,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":310,"price":61.22,"value":18978.2,"ownership":{"direct":true},"balance_after":223851,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616741,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":200,"price":61.23,"value":12246.0,"ownership":{"direct":true},"balance_after":224161,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616740,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":100,"price":61.24,"value":6124.0,"ownership":{"direct":true},"balance_after":224361,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616739,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":600,"price":61.25,"value":36750.0,"ownership":{"direct":true},"balance_after":224461,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616738,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":100,"price":61.27,"value":6127.0,"ownership":{"direct":true},"balance_after":225061,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":616737,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-24T15:54:31.000Z","date":"2006-02-22","kind":"sale","acquired":false,"shares":500,"price":61.28,"value":30640.0,"ownership":{"direct":true},"balance_after":225161,"source":{"system":"sec-edgar","filing":"0001179110-06-004677","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004677/edgar.xml","form_type":"4"}},{"id":618061,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested 20% on the January 30, 2003, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at January 30, 2007."}],"balance_after":6586,"derivative":{"exercise_price":16.4375,"expiration_date":"2012-01-29","underlying":"Common Stock","underlying_shares":862},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618060,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":1888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Options vested 20% on the November 8, 2001, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at November 8, 2005."}],"balance_after":0,"derivative":{"exercise_price":11.7579,"expiration_date":"2010-11-07","underlying":"Common Stock","underlying_shares":1888},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618059,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Options vested 20% on the April 18, 2002, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at April 18, 2006."}],"balance_after":1000,"derivative":{"exercise_price":9.81,"expiration_date":"2011-04-17","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618058,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested 20% on the July 20, 2001, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at July 20, 2005."}],"balance_after":0,"derivative":{"exercise_price":9.3438,"expiration_date":"2010-07-20","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618057,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options vested 20% on the April 5, 2001, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at April 5, 2005."}],"balance_after":0,"derivative":{"exercise_price":7.4063,"expiration_date":"2010-04-05","underlying":"Common Stock","underlying_shares":4800},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618056,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":3208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested 20% on the January 18, 2002, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at January 18, 2006."}],"balance_after":0,"derivative":{"exercise_price":7.3985,"expiration_date":"2001-01-17","underlying":"Common Stock","underlying_shares":3208},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618055,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":11624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vested 20% on the July 22, 2000, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at July 22, 2004."}],"balance_after":0,"derivative":{"exercise_price":7.2969,"expiration_date":"2009-07-21","underlying":"Common Stock","underlying_shares":11624},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618054,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested 20% on the January 26, 2001, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at January 26, 2005."}],"balance_after":0,"derivative":{"exercise_price":7.0782,"expiration_date":"2010-01-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618053,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":58664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vested 20% on the January 26, 2000, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at January 26, 2004."}],"balance_after":0,"derivative":{"exercise_price":4.4688,"expiration_date":"2009-01-25","underlying":"Common Stock","underlying_shares":58664},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618052,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vested 20% on the July 23, 1999, the first anniversary date of the grant.  The balance vested every three months thereafter and was fully vested at July 23, 2003."}],"balance_after":0,"derivative":{"exercise_price":2.8594,"expiration_date":"2008-07-22","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618051,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":862,"price":16.4375,"value":14169.125,"ownership":{"direct":true},"balance_after":225661,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618050,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":1000,"price":9.81,"value":9810.0,"ownership":{"direct":true},"balance_after":224799,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618049,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":3208,"price":7.3985,"value":23734.388,"ownership":{"direct":true},"balance_after":223799,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618048,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":1888,"price":11.7579,"value":22198.9152,"ownership":{"direct":true},"balance_after":220591,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618047,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":11624,"price":7.2969,"value":84819.1656,"ownership":{"direct":true},"balance_after":218703,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618046,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":3000,"price":9.3438,"value":28031.4,"ownership":{"direct":true},"balance_after":207079,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618045,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":4800,"price":7.4063,"value":35550.24,"ownership":{"direct":true},"balance_after":204079,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618044,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":2000,"price":7.0782,"value":14156.4,"ownership":{"direct":true},"balance_after":199279,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618043,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":58664,"price":4.4688,"value":262157.6832,"ownership":{"direct":true},"balance_after":197279,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":618042,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2006-02-15T22:50:45.000Z","date":"2006-02-13","kind":"exercise","acquired":true,"shares":12000,"price":2.8594,"value":34312.8,"ownership":{"direct":true},"balance_after":138615,"source":{"system":"sec-edgar","filing":"0001179110-06-004011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006004011/edgar.xml","form_type":"4"}},{"id":621585,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Non-qualified Stock Option (right to buy)","published_at":"2006-01-28T00:57:28.000Z","date":"2006-01-25","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options have a five year vesting schedule. 20% of the options will vest on January 25, 2007, the first anniversary date of the grant.  The balance will vest 5% every three months thereafter until fully vested on January 25, 2011."}],"balance_after":65000,"derivative":{"exercise_price":58.01,"expiration_date":"2016-01-25","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001179110-06-002227","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911006002227/edgar.xml","form_type":"4"}},{"id":627638,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":500,"price":54.12,"value":27060.0,"ownership":{"direct":true},"balance_after":126615,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627637,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":200,"price":54.07,"value":10814.0,"ownership":{"direct":true},"balance_after":127115,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627636,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":1900,"price":54.04,"value":102676.0,"ownership":{"direct":true},"balance_after":127315,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627635,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":2000,"price":54.05,"value":108100.0,"ownership":{"direct":true},"balance_after":129215,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627634,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":600,"price":54.03,"value":32418.0,"ownership":{"direct":true},"balance_after":131215,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627633,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":200,"price":54,"value":10800.0,"ownership":{"direct":true},"balance_after":131815,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627632,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":712,"price":54.02,"value":38462.24,"ownership":{"direct":true},"balance_after":132015,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627631,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":600,"price":53.99,"value":32394.0,"ownership":{"direct":true},"balance_after":132727,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627630,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":400,"price":54.01,"value":21604.0,"ownership":{"direct":true},"balance_after":133327,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627629,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":688,"price":53.97,"value":37131.36,"ownership":{"direct":true},"balance_after":133727,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627628,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":900,"price":53.95,"value":48555.0,"ownership":{"direct":true},"balance_after":134415,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":627627,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-11-24T01:26:24.000Z","date":"2005-11-22","kind":"sale","acquired":false,"shares":11300,"price":53.96,"value":609748.0,"ownership":{"direct":true},"balance_after":135315,"source":{"system":"sec-edgar","filing":"0001179110-05-021775","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005021775/edgar.xml","form_type":"4"}},{"id":633312,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":400,"price":42.08,"value":16832.0,"ownership":{"direct":true},"balance_after":146615,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":633311,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":300,"price":42.06,"value":12618.0,"ownership":{"direct":true},"balance_after":147015,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":633310,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":3800,"price":42.07,"value":159866.0,"ownership":{"direct":true},"balance_after":147315,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":633309,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":1000,"price":42.11,"value":42110.0,"ownership":{"direct":true},"balance_after":151115,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":633308,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":1500,"price":42.12,"value":63180.0,"ownership":{"direct":true},"balance_after":152115,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":633307,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":2000,"price":42.14,"value":84280.0,"ownership":{"direct":true},"balance_after":153615,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":633306,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":500,"price":42.16,"value":21080.0,"ownership":{"direct":true},"balance_after":155615,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":633305,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Common Stock","published_at":"2005-09-01T01:23:31.000Z","date":"2005-08-31","kind":"sale","acquired":false,"shares":500,"price":42.1401,"value":21070.05,"ownership":{"direct":true},"balance_after":156115,"source":{"system":"sec-edgar","filing":"0001179110-05-017259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005017259/edgar.xml","form_type":"4"}},{"id":635452,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":17298,"kind":"person","name":"Yang Taiyin","position":1,"cik":"0001334505","reported_name":"YANG TAIYIN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Pharm Dev & Mfg"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2005-07-30T00:37:11.000Z","date":"2005-07-27","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest 20% on July 27, 2006, the first anniversary date of the grant. The remaining balance will vest quarterly over the next four years."}],"balance_after":50000,"derivative":{"exercise_price":43.97,"expiration_date":"2015-07-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-05-015038","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911005015038/edgar.xml","form_type":"4"}}]}